Physician profile
Ming Zhang
NPI 1851957674
$2,704.97
in general payments reported to CMS, 2019-2025
21 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $45.79 · 2024: $1,442 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,704.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $472.91 | 2024-2025 | Symplicity G3, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Amgen INC. | $287.47 | 2024-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $263.30 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.48 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $171.73 | 2025 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $159.78 | 2024-2025 | Camzyos |
| Boston Scientific Corporation | $148.79 | 2025 | Emblem Mri S-Icd, Watchman Access System |
| Penumbra, INC. | $144.84 | 2024 | Indigo System |
| Pfizer INC. | $139.89 | 2023-2024 | |
| Abiomed | $131.52 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $124.77 | 2024 | Winrevair |
| Astrazeneca Pharmaceuticals Lp | $124.49 | 2025 | |
| Edwards Lifesciences Corporation | $77.73 | 2025 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $72.28 | 2025 | Wegovy |
| Chiesi USA, INC. | $58.36 | 2024 | Cleviprex, Kengreal |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $36.25 | 2025 | Ecc Solutions, Lm Accessories |
| Heartflow, INC. | $26.85 | 2025 | |
| Bridgebio Pharma, INC. | $25.64 | 2025 | Attruby |
| Shockwave Medical, INC | $22.20 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $20.82 | 2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $15.87 | 2025 | Tryvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.